News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘ProstateCancer’ clear

  • Scientists at Dana-Farber report they have blocked the development of prostate tumors in cancer-prone mice by knocking out a molecular unit they described as a "powerhouse" that drives runaway cell growth.

Tags: BasicResearch, ProstateCancer

  • Dana-Farber scientists have discovered a molecular switch that enables advanced prostate cancers to spread without stimulation by male hormones, a finding that could serve as a treatment target for castration-resistant prostate cancers.

Tags: BasicResearch, ProstateCancer

  • New research from the Dana-Farber/Brigham and Women's Cancer Center shows that newer, more expensive treatment options for prostate cancer were adopted rapidly and widely during 2002–2005 without proof of their cost-effectiveness.

Tags: ProstateCancer

  • Dana-Farber researchers find many men with low-risk, localized prostate cancers can safely choose observation instead of undergoing immediate treatment and have a better quality of life while reducing health care costs.

Tags: ProstateCancer, PopulationScience

  • Hormone-blocking therapy for prostate cancer doesn’t raise the risk of fatal heart attacks - as some recent studies had suggested - according to a new report from Dana-Farber/Brigham and Women’s Cancer Center.

Tags: Hormones, ProstateCancer

  • Dr. Philip Kantoff says the United States Preventive Services Task Force's conclusion that prostate-specific antigen (PSA) testing provides limited value is the wrong message.

Tags: ProstateCancer

  • A new blood test increases the accuracy of prostate cancer diagnosis and could eliminate tens of thousands of unneeded prostate biopsies annually, Dana-Farber researchers report.

Tags: BasicResearch, ProstateCancer

  • First study of the genomic composition of prostate cancer shows many patients have gene mutations that can be targeted with existing or potential drugs.

Tags: Genomics, ProstateCancer, TargetedTherapy

  • Immunotherapy, genomic profiling, and investigating game-changing drug therapies topped the list of most important cancer research and clinical developments at Dana-Farber Cancer Institute in 2014.

Tags: EGFR, Genomics, LungCancer, OvarianCancer, ProstateCancer, Lymphoma, Immunotherapy

  • Dana-Farber researchers have demonstrated that a hormone-depleting drug can help eliminate or nearly eliminate aggressive prostate cancers that have yet to spread beyond the prostate.

Tags: Hormones, ProstateCancer, TranslationalResearch

Showing 11-20 of 27 items